Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 24;6(2):e004181. doi: 10.1136/bmjgh-2020-004181

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Sensitivity analysis of the cost-effectiveness of the ‘Observed MSF’ model of care with 2017 DAA costs compared with no treatment. Costs shown in US$. The reduced FibroScan cost (US$3.89) scenario reflects the FibroScan cost estimated in similar income country setting with higher volume (GDP adjusted cost from Cambodia, US$2017; $4.31). Dark and light blue bars displayed when two values of a parameter were examined and resulted in ICER values lower and above the baseline ICER value (US$634). DAA, direct-acting antiviral therapy; GDP, Gross Domestic Product; ICER, incremental cost-effectiveness ratio; MSF, Médecins sans Frontières; SVR, sustained virological response (at 12 weeks).